SCHEMBL24627697

SCHEMBL24627697

CCCCCCCCCC(CCCCCCCCC)OC(=O)CCCCC(CCCCC(=O)OC(CCCCCCCCC)CCCCCCCCC)OC(=O)CCCCN(CCCCC(=O)OC(CCCCC(=O)OC(CCCCCCCCC)CCCCCCCCC)CCCCC(=O)OC(CCCCCCCCC)CCCCCCCCC)CCCCN1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
MAPT P10636 2/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 4/20 0.44
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
PRKCA P17252 1/20 0.41
PRKCE Q02156 1/20 0.41
PRKCQ Q04759 1/20 0.41
PRKCD Q05655 1/20 0.41
BCHE P06276 3/20 0.41
TLR2 O60603 1/20 0.39
MEN1 O00255 1/20 0.39
GMNN O75496 1/20 0.39
HSP90AA1 P07900 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NR1H4 Q96RI1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627862 0.96 GAA (0.43) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL24628012 0.95 GAA (0.45) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL17367570 0.95 GAA (0.47) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL25525594 0.91 ALDH1A1 (0.47) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL24627804 0.91 MAPK1 (0.44) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL25530864 0.90 MAPK1 (0.48) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL31420400 0.89 GAA (0.47) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL25919340 0.89 ALDH1A1 (0.47) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL25525493 0.89 ALDH1A1 (0.47) GAAMAPTMAPK1LMNAALDH1A1
SCHEMBL24627850 0.89 GAA (0.45) GAAMAPTMAPK1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220218622-A1 IONIZABLE LIPIDS AND METHODS OF MANUFACTURE AND USE THEREOF NPC1L1, PLA2G4A, PLA2G2A GAA 975/4885MAPT 2748/4885MAPK1 4647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.